Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:91192914:5167 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:91192914:5167?format=raw |
LEADER: 05167mam a2200421 a 4500
001 4070049
005 20221027030830.0
008 020403t20022002pauaf b 001 0 eng d
010 $a 2002066093
015 $aGBA2-V7676
020 $a0781735157
035 $a(OCoLC)ocm49531458
035 $9AVD7011HS
035 $a4070049
040 $aDLC$cDLC$dUKM$dC#P$dVET$dOrLoB-B
042 $apcc
050 00 $aRC382$b.P257 2002
082 00 $a616.8/3$221
096 $aWL 359 P2473 2002
245 00 $aParkinson's disease and movement disorders /$ceditors, Joseph J. Jankovic, Eduardo Tolosa.
246 14 $aParkinson's disease & movement disorders
250 $a4th ed.
260 $aPhiladelphia, PA :$bLippincott Williams & Wilkins,$c[2002], ©2002.
300 $axiv, 721 pages, 2 unnumbered pages of plates :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tBiochemical and Functional Organization of the Basal Ganglia /$rAnne B. Young and John B. Penney, Jr. --$g2.$tMotor Control and Movement Disorders /$rRodger J. Elble --$g3.$tNeurotransmitters and Pharmacology of the Basal Ganglia /$rPeter Riederer, Manfred Gerlach and Paul Foley --$g4.$tMechanisms of Cell Death in Parkinson's Disease /$rC. Warren Olanow, William G. Tatton and Peter Jenner --$g5.$tAnimal Models of Movement Disorders /$rGiselle M. Petzinger and Michael W. Jakowec --$g6.$tEpidemiology of Movement Disorders /$rAnette Schrag --$g7.$tEtiology of Parkinson's Disease /$rCaroline M. Tanner, Samuel M. Goldman and G. Webster Ross --$g8.$tLevodopa in Parkinson's Disease: Mechanisms of Action and Pathophysiology of Late Failure /$rWerner Poewe and Gregor Wenning --$g9.$tTherapeutic Strategies in Parkinson's Disease /$rJoseph J. Jankovic --$g10.$tProgressive Supranuclear Palsy /$rEduardo Tolosa, Francesc Valldeoriola and Pau Pastor --$g11.$tMultiple System Atrophy /$rSid Gilman --
505 80 $g12.$tCorticobasal Degeneration /$rRajeev Kumar, Catherine Bergeron and Anthony E. Lang --$g13.$tSecondary Parkinsonism /$rDavid E. Riley --$g14.$tHuntington's Disease /$rKevin M. Biglan and Ira Shoulson --$g15.$tChorea /$rChristopher G. Goetz and Stacy Horn --$g16.$tBallism /$rFrancisco Grandas --$g17.$tNeurologic Aspects of Wilson's Disease: Clinical Manifestations and Treatment Considerations /$rPeter LeWitt and Ronald Pfeiffer --$g18.$tNeuropathology of Parkinsonian Disorders /$rDennis W. Dickson --$g19.$tTremors: Differential Diagnosis, Pathophysiology, and Therapy /$rGunther Deuschl and Jens Volkmann --$g20.$tMyoclonus and Startle Syndromes /$rHiroshi Shibasaki --$g21.$tNeuropharmacology and Treatment of Myoclonus /$rSantiago Gimenez-Roldan --$g22.$tTics and Tourette's Syndrome /$rJoseph J. Jankovic --$g23.$tDystonic Disorders /$rJoseph J. Jankovic and Stanley Fahn --$g24.$tTreatment of Dystonia /$rStacy Horn and Cynthia L. Comella --$g25.$tDrug-induced Dyskinesias /$rOscar S. Gershanik --
505 80 $g26.$tSleep-related Movement Disorders and Restless Legs Syndrome /$rClaudia Trenkwalder --$g27.$tAtaxia and Other Cerebellar Syndromes /$rSteve G. Massaquoi and Mark Hallett --$g28.$tDisorders of Gait /$rEvzen Ruzicka and Joseph J. Jankovic --$g29.$tParoxysmal Dyskinesias /$rKapil D. Sethi --$g30.$tStereotypy and Catatonia /$rJoseph H. Friedman --$g31.$tMovement Disorders in Children /$rHarvey S. Singer --$g32.$tRigidity and Spasticity /$rVictor S. C. Fung and Philip D. Thompson --$g33.$tMuscle Cramps, Stiffness, and Myalgia /$rYadollah Harati and Opas Nawasiripong --$g34.$tFrontotemporal Dementia and Other Tauopathies /$rHuw R. Morris --$g35.$tCognitive and Behavioral Aspects of Basal Ganglia Diseases /$rBruno Dubois and Bernard Pillon --$g36.$tPsychogenic Movement Disorders /$rWilliam C. Koller, Jill Marjama-Lyons and Alexander I. Troster --$g37.$tHereditary Ataxias /$rThomas Klockgether --$g38.$tGenetics of Parkinsonism /$rThomas Gasser --
505 80 $g39.$tNeuroacanthocytosis /$rJuha O. Rinne and Myung Sik Lee --$g40.$tInfectious and Transmissible Movement Disorders /$rFrancisco Cardoso --$g41.$tMagnetic Resonance Imaging of Movement Disorders /$rMario Savoiardo and Marina Grisoli --$g42.$tMovement Disorders: Functional Imaging /$rDavid J. Brooks --$g43.$tBotulinum Toxin in Movement Disorders and Spasticity /$rCharles H. Adler --$g44.$tSurgery for Parkinson's Disease and Hyperkinetic Movement Disorders /$rJoachim K. Krauss and Robert G. Grossman --$g45.$tNeural and Stem Cell Transplantation /$rOlle Lindvall and Peter Hagell --$g46.$tDeep Brain Stimulation /$rRajeev Kumar.
650 0 $aParkinson's disease.$0http://id.loc.gov/authorities/subjects/sh85098115
650 0 $aMovement disorders.$0http://id.loc.gov/authorities/subjects/sh85088017
650 2 $aMovement Disorders.$0https://id.nlm.nih.gov/mesh/D009069
650 2 $aParkinson Disease.$0https://id.nlm.nih.gov/mesh/D010300
700 1 $aJankovic, Joseph.$0http://id.loc.gov/authorities/names/n84176324
700 1 $aTolosa, Eduardo.$0http://id.loc.gov/authorities/names/n85321583
852 00 $boff,hsl$hRC382$i.P257 2002 Q